Citation

Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ.: Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease. J Med Chem, Volume 54 (19), 2011

Authors

Agoram B, Bunnage ME, Burrows JL, Clarke NP, Dillon BR, Entwistle DA, Evans SM, Fairman DA, Feeder N, Fulton CK, Glossop PA, Harrison AC, James K, Machin I, Middleton DS, Perros-Huguet C, Price DA, Roberts D, Spence FJ., Strang RS, Stuart EF, Trevethick MA, Watson CA, Wood A, Yeadon M

Journal

J Med Chem

Year

2011

DOI

10.1021/jm200884j

PubMed

21870878

Machine-readable

REST APIRDF